The Pneumonia Testing market size is USD 1.4 Bn in 2026.
The Pneumonia Testing market is projected to grow at a CAGR of 10% by 2033.
The market growth is driven by rising pneumonia prevalence, increasing adoption of point-of-care (POC) testing, and advancements in molecular diagnostics technologies.
North America is a dominating region for the Pneumonia Testing market.
Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Thermo Fisher Scientific, and bioMérieux S.A. are some leading industry players in the Pneumonia Testing market.